4 October 2015 - The agenda for the 7 October 2015 TC meeting is now available. The Commission considered the following technologies:

• Tedolizid phosphate (Sivextro) - new medicine
• Insulin degludec with liraglutide (Xultophy) - new combination medicine
• Macitentan (Opsumit) - review of SMR & ASMR
• Fibrinogen (human) with thrombin (human) (Raplixa) - new combination product
• Darunavir ethanolate with cobicistat (Rezolsta) - new combination product

For more details, go to: http://www.has-sante.fr/portail/upload/docs/application/pdf/2015-09/ordre_du_jour_commission_transparence_07102015.pdf